4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-17-051470
CEO and Director bought 37,736 shares at $2.65 ($100,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Director | 2017-08-31 | Purchase | +37,736 | $2.65 | $100,000 | 367,883 | D |
| Derivatives | |||||||
| MENDLEIN JOHN CEO and Director | 2017-08-31 | Purchase · Warrant to Purchase Common Stock | +14,151 | 14,151 | D | ||
| Open-market purchases · 37,736 sh · avg $2.65 · $100,000 | |||||||
Loading xslF345X03/doc4.xml…